Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Genomics and new targets for multiple sclerosis.

Sergio E Baranzini1, Jorge R Oksenberg

  • 1University of California, Department of Neurology, School of Medicine, San Francisco, CA 94143-0435, USA.

Pharmacogenomics
|May 11, 2005
PubMed
Summary

Genetic factors significantly influence multiple sclerosis (MS) risk, progression, and treatment response. Multiple genes interact with environmental factors, and genetic variations contribute to disease susceptibility and development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Circulating Short-Chain Fatty Acid Profile Predicts Functional Outcome After Moderate-to-Severe Traumatic Brain Injury.

Critical care explorations·2026
Same author

Microbiome-derived metabolites from vitamin B2 and B9 pathways modulate MAIT cells from multiple sclerosis patients.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Annals of neurology·2026
Same author

Female-enriched <i>Eggerthella lenta</i> drives neuroinflammation and IFN-γ via host receptor TLR2.

bioRxiv : the preprint server for biology·2026
Same author

The genetics of multiple sclerosis: an updated perspective.

Current opinion in neurology·2026
Same author

Reply to "Comparative Safety Profiles of Ocrelizumab and Rituximab in Multiple Sclerosis Treatment Using Real-World Evidence".

Annals of neurology·2026

Area of Science:

  • Genetics
  • Neuroimmunology
  • Epidemiology

Background:

  • Multiple Sclerosis (MS) is a complex neurological disease with a significant genetic component.
  • Understanding the genetic basis of MS is crucial for identifying at-risk individuals and developing targeted therapies.

Purpose of the Study:

  • To elucidate the role of genetic factors in multiple sclerosis (MS) etiology, disease progression, and therapeutic response.
  • To explore the influence of allelic variants and locus heterogeneity in MS pathogenesis.

Main Methods:

  • Analysis of epidemiological and molecular data.
  • Investigation of genetic variations and their impact on MS.
  • Consideration of gene-gene interactions and environmental factors.

Related Experiment Videos

Main Results:

  • Genes play a primary role in MS susceptibility, progression, and treatment outcomes.
  • Allelic variants in multiple genes contribute to the genetic component of MS.
  • Incomplete penetrance and moderate individual gene effects suggest complex interactions.

Conclusions:

  • Genetic factors are central to multiple sclerosis development and progression.
  • Locus heterogeneity likely contributes to variations in MS susceptibility and pathogenesis among individuals.
  • Future research should focus on gene-environment interactions and complex genetic networks in MS.